POV Blogs
08|06|26
What ChatGPT Ads Mean for Pharma Search
Explore the critical differences between ChatGPT Ads and standard search, the unique regulatory challenges ahead, and the exact steps pharma brands must take now to prepare for inevitable platform access.
06|10|26
A New Blueprint for Brand Campaigns In Pharma Marketing
Pharma marketers can no longer rely on in-market demand alone to drive growth. In a crowded, AI-powered landscape, brands must build connection and familiarity earlier to unlock stronger performance later. This POV reveals the five pillars behind campaigns that drive real ROI.
05|20|26
Google AI Mode & What It Means for Pharma Search
Google’s shift to AI‑generated search is redefining how patients and healthcare professionals discover information. As advertising moves into conversational, intent‑driven experiences, pharma marketers are being pushed to rethink how they show up in moments that increasingly shape decision‑making.
05|15|26
2026 Pharma AI Overviews Report
In the past four years, AI has altered how users and technology discover and engage with information and continues to evolve and reshape the digital landscape. To better understand this transformation, our GEO/SEO team analyzed 10,000 pharmaceutical-specific keywords, uncovering a hidden layer of AI background searches and a rapidly changing landscape where nearly 75% of keywords now trigger AI Overviews and sources shift frequently.
05|11|26
What Adobe Summit 2026 Signals for Pharma Marketing
Adobe Summit 2026 highlighted a major shift in AI, uncovering new implications for how marketing gets done in pharma. Our latest POV from our team that attended this year’s summit explores what this shift means and how pharma marketers can start preparing for what’s next. Readers will gain insight into: Download the POV to learn more.
12|18|25
Beyond the Abstract: Four Converging Trends from ASH 2025
The American Society of Hematology (ASH) Annual Meeting is more than a forum for groundbreaking science; it is a barometer for the future of oncology. The key takeaways from ASH 2025 signal a fundamental shift in the hematologic cancer landscape, driven by a convergence of powerful forces. Download the POV to learn more.
09|24|25
Finding the Unfindable: The Artful Ingenuity of AI-Powered Patient Finding
Millions of patients remain undiagnosed or unaware of effective treatments — delaying care and leaving brands with untapped opportunity. Traditional approaches often fall short, but AI-powered patient-finding is changing the game. Our latest POV explores how a strategic combination of diverse data, cross-disciplinary clinical expertise, and advanced AI tools — what we call Artful Ingenuity […]
08|28|25
Marketing in the Age of Uncertainty: Preparing for a Post-DTC World
As proposed legislation threatens to ban direct-to-consumer (DTC) pharmaceutical advertising, our experts offer a timely perspective on how pharma marketers can navigate this evolving landscape. In an era defined by regulatory uncertainty and shifting patient expectations, this POV outlines actionable strategies to stay compliant, connected and competitive. Download the POV to discover how marketers can lead the next chapter of healthcare engagement with agility and purpose.
03|20|25
SXSW 2025: A Mandate, A Path, A Tool
At SXSW 2025, we heard loud and clear: Pharma marketers are facing the biggest challenge of our careers. But it's also the most rewarding challenge, and one that has sharpened our superpowers. In this POV, we discuss how we can harness these opportunities to navigate the challenges ahead.
03|18|25
The Digital Determinants of Health: Shaping the Future of Well-Being
Download the POV, The Digital Determinants of Health, to discover how understanding digital determinants of health can transform pharmaceutical strategies and drive business success.